Zanamivir is a topic covered in the Johns Hopkins ABX Guide.

To view the entire topic, please or purchase a subscription.

Pediatrics Central™ is an all-in-one application that puts valuable medical information, via your mobile device or the web, in the hands of clinicians treating infants, children, and adolescents. Explore these free sample topics:

Pediatrics Central

-- The first section of this topic is shown below --

INDICATIONS

FDA

  • Uncomplicated acute illness due to influenza A and B infection (patients > 7 yrs of age with < 48hr symptoms).
  • Influenza prophylaxis in those 5 years of age or older.
    • Not proven effective for prophylaxis in nursing home residents.

NON-FDA APPROVED USES

-- To view the remaining sections of this topic, please or purchase a subscription --

Last updated: December 6, 2017

Citation

* When formatting your citation, note that all book, journal, and database titles should be italicized* Article titles in AMA citation format should be in sentence-case
TY - ELEC T1 - Zanamivir ID - 540596 A1 - Pham,Paul,Pharm.D. Y1 - 2017/12/06/ BT - Johns Hopkins ABX Guide UR - https://peds.unboundmedicine.com/pedscentral/view/Johns_Hopkins_ABX_Guide/540596/all/Zanamivir PB - The Johns Hopkins University DB - Pediatrics Central DP - Unbound Medicine ER -